Healthcare

Is the Recent Performance of Sonic Healthcare Limited (ASX:SHL) Stoc...

Is the Recent Performance of Sonic Healthcare Limited (ASX:SHL) Stock Influenced by Its Financial Health?

SDI Limited Financial Strength Amid Market Fluctuations

SDI Limited Financial Strength Amid Market Fluctuations

Respiri Acquires Orb Health Inc. to Strengthen U.S. Market Position

Highlights,Acquisition of Orb Health:,Respiri has successfully acquired,Orb Health Inc.,for,US$9 million,in shares, marking a significant milestone in...

Lumos Diagnostics (ASX:LDX) Shares Up 31%, Business Prospects Need I...

Lumos Diagnostics (ASX:LDX) Shares Up 31%, Business Prospects Need Improvement

Insiders Forfeit AU$265k with Emyria Stock Declining to AU$0.03

Insiders Forfeit AU$265k with Emyria Stock Declining to AU$0.03

A year ago, purchasing shares in Ansell (ASX:ANN) would have yielded...

Highlights:,Ansell Limited (ASX:ANN) shares outperformed the market significantly over the past year.,Total shareholder return outpaces simple share p...

ASX Biotech Companies Focused on Early Cancer Detection

Pioneering Advances in Cancer Detection by ASX-Listed Biotechs

Orthocell Ltd. (ASX:OCC) Secures A$3.18 Million R&D Refund and Stren...

Highlights,Orthocell,Ltd. (,ASX:OCC,) receives,a A,$3.18 million R&D tax refund, boosting its cash reserves to A$33 million.,The company is preparing...

EBR's prospects for its US heart lead improve as the wireless device...

EBR's prospects for its US heart lead improve as the wireless device receives approval for expedited reimbursement.

Optiscan (ASX:OIL) Initiates GI Study in Germany Using Its Initial I...

Optiscan Advances GI Imaging Technology with New Pre-Clinical Study

Is Little Green Pharma (ASX:LGP) Making Prudent Use of Debt?

Is Little Green Pharma (ASX:LGP) Making Prudent Use of Debt?

ASX Quarterly Health Summary: EZZ Scores Big, ReNerve's Initial Post...

EZZ Life Science and Microba Report Strong Q2 FY25 Growth

Lung Imaging Company Cyclopharm (ASX:CYC) Finds Success in the US Ma...

Cyclopharm's Strategic Expansion in the US Healthcare Market

How Will OPT-302 Transform the Future of Eye Disease Treatment?

Highlights,Opthea's lead drug, OPT-302, shows significant promise as a new treatment for challenging eye diseases, such as wet AMD and DME.,If Phase I...

Australian High-Growth Tech Stocks Highlighting Infomedia and Two Ad...

Australian High-Growth Tech Stocks Highlighting Infomedia and Two Additional Companies

Telix Pharmaceuticals (ASX:TLX) Gains After EU Approval for Illuccix...

Highlights,Telix,Pharmaceuticals (,ASX:TLX,) shares jump following European approval.,Illuccix,, the prostate cancer diagnostic agent, gets the green...

ResMed Gains Limelight as Goldman Sachs Sets Bullish Target

Highlights,Strong Performance:,ResMed shares have surged 44% in the past 12 months, showing robust investor confidence in the sleep disorder treatment...

Telix Pharmaceuticals Secures European Authorisation for Prostate Ca...

Highlights,European Approval for Illuccix®:,Telix Pharmaceuticals received a positive decision on its Marketing Authorization Application (MAA) for Il...

Immuron Reports Strong Sales Growth for Travelan® Across Global Mark...

Highlights,Global Sales Surge:,Travelan® global sales reached AUD $2.5 million in the December 2024 Quarter, up 70% from the prior quarter and 249% co...

Telix maintains steady growth, while Pro Medicus secures another con...

Telix maintains steady growth, while Pro Medicus secures another contract.